Pharmacogenomics in general practice: The time has come.

Area of Science:

• Pharmacogenomics
• Genetics
• Clinical Pharmacology

Background:

• Individual responses to medications vary due to genetic differences affecting drug metabolism and efficacy.
• Genetic variations influence both medication exposure and the patient's response.
• Understanding these genetic factors is crucial for personalized medicine.

Purpose of the Study:

• To introduce pharmacogenomic testing to general practitioners.
• To provide guidance on the practical implementation of pharmacogenomic tests in primary care settings.
• To highlight the clinical utility of pharmacogenomic information in medication prescribing.

Main Methods:

• Review of international guidelines and evidence for pharmacogenomic testing.
• Identification of key genes and medications with established clinical benefit.
• Discussion of practical considerations for integrating pharmacogenomic testing into general practice.

Main Results:

• International guidelines recommend testing for at least 15 genes to inform prescribing for 30 medications.
• Pharmacogenomic testing offers clinical benefits by guiding medication selection and dosing.
• Test results should complement, not replace, clinical judgment and other patient data.

Conclusions:

• Pharmacogenomic testing is a valuable tool for optimizing medication therapy.
• General practitioners can utilize pharmacogenomic insights for patients with complex medication needs or adverse drug reactions.
• Integrating pharmacogenomic testing into routine practice can enhance patient outcomes and medication safety.